Literature DB >> 15219298

The use of rabies immune globulin by emergency physicians.

David A Jerrard1.   

Abstract

We sought to determine the incidence of practice patterns by emergency physicians that are non-compliant with present day World Health Organization recommendations regarding the administration of rabies immune globulin (RIG) in the prophylaxis of rabies. Of the 110 patients receiving RIG for rabies-prone wounds, 46 patients (41.8%; 95% CI 32-51.6%) were felt to have received the immunoglobulin in improper amounts at the bite site. In 43 of these 46 patients (92.8%; 95% CI 81.1-98.3%), there was a physician-written order on the chart directing the RIG be given in the older 50:50 method (one-half at the bite site, one-half elsewhere). Large numbers of patients still receive RIG inappropriately according to World Health Organization guidelines and more recently issued recommendations from the Advisory Committee on Immunization Practices. Treatment failures have been felt to occur secondary to inadequate RIG levels in wounds prophylaxed using the outdated recommendation. Emergency physicians need to be well versed and up to date with newer guidelines when prophylaxing patients for possible rabies exposure.

Entities:  

Mesh:

Year:  2004        PMID: 15219298     DOI: 10.1016/j.jemermed.2004.02.005

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  7 in total

1.  Human Rabies Postexposure Prophylaxis Knowledge and Retention Among Health Professionals by Using an Online Continuing Education Module: Arizona, 2012 to 2015.

Authors:  Heather Venkat; James Matthews; Jigna Narang; Rebecca Sunenshine; Laura E Adams; Andrean M Bunko; Jessica R White; Craig Levy; Tammy Sylvester
Journal:  Pedagogy Health Promot       Date:  2018-04-06

2.  Using an Emergency Department Syndromic Surveillance System to Evaluate Reporting of Potential Rabies Exposures, Illinois, 2013-2015.

Authors:  Kelley Bemis; Mabel Frias; Megan Toth Patel; Demian Christiansen
Journal:  Public Health Rep       Date:  2017 Jul/Aug       Impact factor: 2.792

3.  Implementation of Clinical Decision Support on Emergency Department Delivery of Human Rabies Immune Globulin.

Authors:  Fangzheng Yuan; Tomona Iso; Elsie Rizk; R Benjamin Saldana; Anh Thu Tran; Ngoc-Anh A Nguyen; Prasanth R Boyareddigari; Daniela Espino; Joshua T Swan
Journal:  JAMA Netw Open       Date:  2022-06-01

4.  Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study.

Authors:  Rita V Burke; Pierantonio Russo; Michael Sicilia; William Wolowich; Novinyo Amega; Huy-Binh Nguyen
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006

5.  Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.

Authors:  Nicholas Hobart-Porter; Michal Stein; Naveh Toh; Novinyo Amega; Huy-Binh Nguyen; James Linakis
Journal:  Hum Vaccin Immunother       Date:  2021-02-09       Impact factor: 4.526

6.  Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis.

Authors:  Grace S Hwang; Elsie Rizk; Lan N Bui; Tomona Iso; Emily I Sartain; Anh Thu Tran; Joshua T Swan
Journal:  Hum Vaccin Immunother       Date:  2019-08-01       Impact factor: 3.452

7.  Current characteristics of animal rabies cases in Thailand and relevant risk factors identified by a spatial modeling approach.

Authors:  Weerapong Thanapongtharm; Sarin Suwanpakdee; Arun Chumkaeo; Marius Gilbert; Anuwat Wiratsudakul
Journal:  PLoS Negl Trop Dis       Date:  2021-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.